The HEPV PPR program enhances the understanding and use of patient perspective data in reimbursement decisions, health technology assessments, and policymaking. FDA, CMS, private insurance providers, health technology assessment organizations, patient advocacy groups, and other policy stakeholders collaborate on this work.
The PPR Working Group
Established in 2020, the PPR Working Group oversees activities, including determining priorities, sharing expectations, managing the work, and identifying opportunities. Barry Liden, JD, Vice President of Patient Engagement at Edwards Lifesciences, chairs the PPR Working Group.